Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jiang, Hong Ni ^a,b   Zeng, Bo ^b   Zhang, Yi ^a   Daskoulidou, Nikoleta ^b   Fan, Hong ^a   Qu, Jie Ming ^a   Xu, Shang Zhong ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL CULTURE; CANCER GRADING; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; MOLECULAR IMAGING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

CALCIUM; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRETINOIN; UP-REGULATION;

EID: 84879538143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067637     Document Type: Article

References (50)

1. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, et al. (2011) Non-small-cell lung cancer. Lancet 378: 1727-1740.
2. Cataldo VD, Gibbons DL, Perez-Soler R, Quintas-Cardama A, (2011) Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med 364: 947-955.
3. Herbst RS, Heymach JV, Lippman SM, (2008) Lung cancer. N Engl J Med 359: 1367-1380.
4. Ciardiello F, Tortora G, (2008) EGFR antagonists in cancer treatment. N Engl J Med 358: 1160-1174.
5. Gilligan D, Nicolson M, Smith I, Groen H, Dalesio O, et al. (2007) Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 369: 1929-1937.
6. Tajeddine N, Gailly P, (2012) TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling. J Biol Chem 287: 16146-16157.
7. Shapovalov G, Lehen'kyi V, Skryma R, Prevarskaya N, (2011) TRP channels in cell survival and cell death in normal and transformed cells. Cell calcium 50: 295-302.
8. Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, et al. (2010) Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res 70: 418-427.
9. Zeng B, Yuan C, Yang X, Atkin SL, Xu SZ, (2013) TRPC Channels and Their Splice Variants are Essential for Promoting Human Ovarian Cancer Cell Proliferation and Tumorigenesis. Curr Cancer Drug Targets 13: 103-116.
10. Guilbert A, Dhennin-Duthille I, Hiani YE, Haren N, Khorsi H, et al. (2008) Expression of TRPC6 channels in human epithelial breast cancer cells. BMC cancer 8: 125.
11. Aydar E, Yeo S, Djamgoz M, Palmer C, (2009) Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy. Cancer Cell Int 9: 23.
12. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, et al. (2008) Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 47: 2068-2077.
13. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66: 2038-2047.
14. Pigozzi D, Ducret T, Tajeddine N, Gala JL, Tombal B, et al. (2006) Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line. Cell Calcium 39: 401-415.
15. Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, et al. (2007) Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. Febs J 274: 6365-6377.
16. Bomben VC, Sontheimer HW, (2008) Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 41: 98-121.
17. 2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells. J Neurosci 26: 10658-10666.
18. 2+ mobilization mediated by transient receptor potential canonical 3 is associated with thrombin-induced morphological changes in 1321N1 human astrocytoma cells. J Neurosci Res 86: 2722-2732.
19. Cai R, Ding X, Zhou K, Shi Y, Ge R, et al. (2009) Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 125: 2281-2287.
20. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ, (2009) Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 28: 1320-8.
21. Beck B, Lehen'kyi V, Roudbaraki M, Flourakis M, Charveron M, et al. (2008) TRPC channels determine human keratinocyte differentiation: new insight into basal cell carcinoma. Cell Calcium 43: 492-505.
22. Zhang Q, He J, Lu W, Yin W, Yang H, et al. (2010) Expression of transient receptor potential canonical channel proteins in human non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 13: 612-616.
23. Saito H, Minamiya Y, Watanabe H, Takahashi N, Ito M, et al. (2011) Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung. Ann Surg Oncol 18: 3377-3383.
24. Giltnane JM, Rimm DL, (2004) Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 1: 104-111.
25. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press.
26. Xu SZ, Zeng F, Lei M, Li J, Gao B, et al. (2005) Generation of functional ion-channel tools by E3 targeting. Nat Biotechnol 23: 1289-1293.
27. Bhandari S, Watson N, Long E, Sharpe S, Zhong W, et al. (2008) Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney. J Histochem Cytochem 56: 733-743.
28. Xu HT, Ma L, Qi FJ, Liu Y, Yu JH, et al. (2006) Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma. Pathol Int 56: 375-380.
29. Xu SZ, Zeng B, Daskoulidou N, Chen GL, Atkin SL, et al. (2012) Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure. Toxicol Sci 125: 56-68.
30. Jiang H, Zeng B, Chen GL, Bot D, Eastmond S, et al. (2012) Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels. Biochem Pharmacol 83: 923-931.
31. 2+ channels in native vascular smooth muscle cells. Circ Res 88: 84-87.
32. Xu SZ, Sukumar P, Zeng F, Li J, Jairaman A, et al. (2008) TRPC channel activation by extracellular thioredoxin. Nature 451: 69-72.
33. Xu SZ (2011) Assessing TRPC Channel Function Using Pore-Blocking Antibodies. In: Zhu MX, editor. TRP channels. New York: CRC press. 149-165.
34. Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, et al. (2006) A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res 98: 1381-1389.
35. Flemming R, Xu SZ, Beech DJ, (2003) Pharmacological profile of store-operated channels in cerebral arteriolar smooth muscle cells. Br J Pharmacol 139: 955-965.
36. Riccio A, Medhurst AD, Mattei C, Kelsell RE, Calver AR, et al. (2002) mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res Mol Brain Res 109: 95-104.
37. Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, et al. (2011) High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem 28: 813-822.
38. 2+ influx in differentiating human stem cells and platelets. Biochim Biophys Acta 1539: 243-255.
39. Arrieta O, Gonzalez-De la Rosa CH, Arechaga-Ocampo E, Villanueva-Rodriguez G, Ceron-Lizarraga TL, et al. (2010) Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer. J Clin Oncol 28: 3463-3471.
40. Zhou RJ, Yang XQ, Wang D, Zhou Q, Xia L, et al. (2012) Anti-tumor effects of all-trans retinoic acid are enhanced by genistein. Cell Biochem Biophys 62: 177-184.
41. Kawakami S, Suzuki S, Yamashita F, Hashida M, (2006) Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes. J Control Release 110: 514-521.
42. 2+ entry in decidualization of human endometrial stromal cells. Mol Endocrinol 26: 846-858.
43. Kwan HY, Shen B, Ma X, Kwok YC, Huang Y, et al. (2009) TRPC1 associates with BKCa channel to form a signal complex in vascular smooth muscle cells. Circ Res 104: 670-678.
44. Yu Z, Lin J, Xiao Y, Han J, Zhang X, et al. (2005) Induction of cell-cycle arrest by all-trans retinoic acid in mouse embryonic palatal mesenchymal (MEPM) cells. Toxicol Sci 83: 349-354.
45. Mangiarotti R, Danova M, Alberici R, Pellicciari C, (1998) All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells. Br J Cancer 77: 186-191.
46. Prevarskaya N, Zhang L, Barritt G, (2007) TRP channels in cancer. Biochim Biophys Acta 1772: 937-946.
47. 2+ entry pathway in human retinoblastoma cells. J Pharmacol Sci 95: 403-419.
48. Jiang J, Li MH, Inoue K, Chu XP, Seeds J, et al. (2007) Transient Receptor Potential Melastatin 7 like current in human head and neck carcinoma cells: Role in Cell Proliferation. Cancer Res 67: 10929-10938.
49. 2+ transporter type 1. J Biol Chem 278: 15381-15389.
50. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, et al. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185.